Ventilator associated pneumonia. Influenza and pneumonia
Conditions
Interventions
Intervention 1: Intervention group: Gavage of Trachyspermum Ammi syrup 10%, from the first day of enteral feeding, 10 ml, three times a day for ten days. Intervention 2: Control group: gavage of plac
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having an oral endotracheal tube Receiving mechanical ventilation ICU hospitalization due to trauma
Exclusion criteria
Exclusion criteria: Having pneumonia at the time of admission Cardiopulmonary diseases Lung contusion Pulmonary thromboembolism Atelectasis Inflammatory diseases Digestive diseases Liver and biliary diseases History of allergies to herbal drugs Symptoms of pulmonary aspiration Weak immune system Substance abuse and addiction Extubation before 10 days Death or ICU discharge before 10 days Sudden change in hemodynamic status Complications such as hives, itching and skin rashes that can be a sign of allergy to Trachyspermum Ammi syrup
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventilator-associated pneumonia. Timepoint: Ventilator-associated pneumonia will be assessed on the fifth and tenth day of the intervention. Method of measurement: Ventilator-associated pneumonia will be assessed by an infectious disease specialist using the Clinical Lung Infection Scale (CPIS). CPIS includes six criteria, including temperature, white blood cell count, tracheal secretion, oxygenation, culture and smear of tracheal secretion, and chest x-ray. Each of criteria is given a score of zero to two. The maximum score of this tool is 10. VAP is diagnosed if the sum of scores is equal to or greater than 6. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mehdi Ahmadinejad
Kerman University of Medical Sciences
Outcome results
None listed